Carcinoma, Hepatocellular: all 3,249 studies
Page 29 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular CarcinomaStatus unknownNCT01713244Not applicable
- Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer DiagnosisWithdrawnNCT01710293Not applicable
- Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to SurgeryTerminatedNCT01690715
- Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic LiverTerminatedNCT01686880Phase 2
- Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated FrequencyCompletedNCT01686412Not applicable
- Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 ExpressionStatus unknownNCT01681446Phase 3
- Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular CarcinomaStatus unknownNCT01677468Not applicable
- Transarterial Chemoembolization Prior to Transplantation for Hepatocellular CarcinomaTerminatedNCT01676194Phase 3
- Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)WithdrawnNCT01669668Phase 2
- Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation TherapyStatus unknownNCT01668381
- Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaCompletedNCT01668134Phase 1
- Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01666756Phase 1
- STA-9090 in Patients With Advanced Hepatocellular CancerCompletedNCT01665937Phase 1
- Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.WithdrawnNCT01659346Not applicable
- Hepatocellular Carcinoma Growth and Molecular AggressivenessCompletedNCT01657695
- Study of ARQ 197 in Hepatocellular Carcinoma (HCC)CompletedNCT01656265Phase 1
- Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal SurgeryStatus unknownNCT01655641Phase 2/3
- Hypofractionated Proton Beam Radiotherapy for Hepatocellular CarcinomaCompletedNCT01643824Not applicable
- Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)CompletedNCT01643447Not applicable
- Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal HypertensionCompletedNCT01642446Not applicable
- Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular CarcinomaCompletedNCT01641276Not applicable
- Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsCompletedNCT01640522Not applicable
- Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid TumorsCompletedNCT01628640Phase 1
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver CancerCompletedNCT01624285Phase 2
- Adult-to-Adult Living Donor Transplant Cohort StudyCompletedNCT01619475
- Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular CarcinomaWithdrawnNCT01618253Phase 1
- Prospective Liver Tumor (ProLiT) DatabaseStatus unknownNCT01607788
- TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular CarcinomaStatus unknownNCT01605734Phase 2
- Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous ThrombusTerminatedNCT01600196Phase 4
- Effects of Telephone Consultations on Discharged Liver CancerCompletedNCT01595243Not applicable
- The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant ListStatus unknownNCT01575717Not applicable
- Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive DiagnosisCompletedNCT01575574Phase 4
- Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular CarcinomaStatus unknownNCT01570166Not applicable
- Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan CriteriaStatus unknownNCT01570075Phase 4
- Temsirolimus as Second-line Therapy in HCCStatus unknownNCT01567930Phase 2
- Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast MediaStatus unknownNCT01563484
- Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaStatus unknownNCT01556815Phase 2
- Lenalidomide as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01545804Phase 2
- Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)CompletedNCT01540461Phase 1
- Sorafenib in Hepatocellular Carcinoma Clinical Practice in ItalyCompletedNCT01539681
- Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACETerminatedNCT01539018Phase 2
- S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01533324Phase 2
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Recurrence of Hepatocellular CarcinomaCompletedNCT01520779
- A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)CompletedNCT01519232
- Procalcitonin in Hepatocellular CarcinomaCompletedNCT01518829
- RCT on Adjuvant TACE After Hepatectomy for HCCCompletedNCT01512407Not applicable
- Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer PatientsTerminatedNCT01507740
- A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01507168Phase 2
- Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular CarcinomaCompletedNCT01507064Phase 2
- Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNCT01506115Not applicable
- Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic LiverWithdrawnNCT01501240
- Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentStatus unknownNCT01492127Not applicable
- Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular CarcinomaCompletedNCT01490203
- Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT01489566Phase 3
- Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular CarcinomaWithdrawnNCT01489410Not applicable
- Major RF Ablations of Hepatomas Under MR Thermometry MonitoringTerminatedNCT01486134Not applicable
- Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell CarcinomaCompletedNCT01482520
- SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular CarcinomaCompletedNCT01482442Phase 3
- Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma PatientsCompletedNCT01481805
- Sorafenib VS TACE in HCC Patients With Portal Vein InvasionTerminatedNCT01480817Phase 2
- Accuracy Assessment for Computer-assisted Surgical Interventions of the LiverCompletedNCT01474694
- Hepatocellular Carcinoma Registry for Turkey (3K Trial)CompletedNCT01473121
- A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT01462903Phase 1
- Study of Postoperative 3D-CRT/IMRT in Hepatocellular CarcinomaCompletedNCT01456156Not applicable
- A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)Status unknownNCT01451658Phase 4
- Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)CompletedNCT01447667Not applicable
- Transient Elastography in Hepatectomy for Hepatocellular CarcinomaStatus unknownNCT01441453Not applicable
- A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.WithdrawnNCT01441388Phase 1
- Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular CarcinomaStatus unknownNCT01438450Phase 2/3
- Trial of Ablation of Small Hepatocellular Carcinomas in Patients of CirrhosisStatus unknownNCT01438437Phase 4
- Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)WithdrawnNCT01432314Phase 2
- Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01429961Phase 2
- A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular CarcinomaTerminatedNCT01425996Phase 1/2
- Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced HepatocarcinomaCompletedNCT01418729Phase 2
- Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular CarcinomaStatus unknownNCT01415063Phase 4
- Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and HepatocarcinomaCompletedNCT01411579
- Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in JapanCompletedNCT01411436
- Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT01409499Phase 4
- Sorafenib in First-line Treatment of Advanced B Child Hepatocellular CarcinomaTerminatedNCT01405573Phase 3
- Use of N-Acetylcysteine During Liver ProcurementCompletedNCT01394497Phase 2
- Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)Status unknownNCT01393197Not applicable
- Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular CarinomasStatus unknownNCT01393093Not applicable
- Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)Status unknownNCT01392131Phase 1/2
- Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular CarcinomaCompletedNCT01390194
- Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingCompletedNCT01387503Not applicable
- Resection for Multiple Hepatocellular Carcinomas (HCC)CompletedNCT01387061Not applicable
- Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)TerminatedNCT01381211Phase 2
- The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular CarcinomaStatus unknownNCT01380392
- Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular CarcinomaStatus unknownNCT01377220Phase 2
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01374750Phase 2
- AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the LiverCompletedNCT01361061
- AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)CompletedNCT01360255
- Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B CirrhosisCompletedNCT01357486Phase 2
- Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of DiseaseCompletedNCT01355107
- Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +AxitinibCompletedNCT01352728Phase 2
- Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cmStatus unknownNCT01351194Phase 4
- Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT ScanStatus unknownNCT01350726
- Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor ThrombosisStatus unknownNCT01350206Phase 4